The report ” Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 201six “, has actually been all set based on an in-depth market analysis along with inputs from industry experts.
GlobalData’s clinical trial report, Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016″ provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Lymphocytic Leukemia (CLL). Report involves an overview of trial numbers and their standard enrollment in top countries conducted across the globe. The report provides coverage of illness clinical trials by region, country (G7 & E7), phase, trial status, end points standing and sponsor type. Report additionally provides prominent drugs for in-progression trials (based on variety of ongoing trials). GlobalData Clinical Trial Reports are generated utilizing GlobalDatas proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ various clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report increases the decision making capabilities and helps to produce an efficient counter strategies to obtain competitive advantage.
Download Sample copy of this Report @
Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top degree data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all of trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all of the unaccomplished trials (Terminated, Suspended and Withdrawn) along with necessity for unaccomplishment
– The Report provides enrollment trends for the past 5 years
– Report provides latest news for the past 3 months
Reasons to buy
– Assists in formulating vital company strategies along with regards to investment
– Helps in determining prominent places for conducting clinical trials which conserves time and cost
– Provides top degree analysis of Global Clinical Trials Market which helps in determining vital company opportunities
– Supports discovering of trials matter and enrollment trends by country in global therapeutics market
– Aids in interpreting the victory rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, local and country level
Browse all of reports Of this Category: http://ift.tt/1Lb7as9
Table of Content :
Table of Components 2
List of Tables 4
List of Figures 5
Report Tips 6
Clinical Trials by Region 7
Clinical Trials and standard Enrollment by Country 8
Top 5 Countries Contributing to Clinical Trials in Asia-Pacific 10
Top 5 Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top 5 Countries Contributing to Clinical Trials in Middle East and Africa 13
Top 5 Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial standing 17
Clinical Trials by E7 Countries: Proportion of Chronic Lymphocytic Leukemia (CLL) to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial standing 20
Clinical Trials by Phase 21
In progression Trials by Phase 22
Clinical Trials by Trial standing 23
Clinical Trials by End Point standing 24
Subjects Recruited Over a Time period 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Chronic Lymphocytic Leukemia (CLL) Therapeutics Clinical Trials 28
Prominent Drugs 29
Latest Clinical Trials News on Chronic Lymphocytic Leukemia (CLL) 30
Jun 09, 2016: AbbVie Reinforces Commitment to Hematologic Oncology at 21st European Hematology Association Annual Congress Including ten Abstracts on Investigational Medicine Venetoclax 30
Jun 06, 2016: AbbVie Builds Upon Robust Physique of IMBRUVICA (ibrutinib) Data along with Phase three Longer-Term Studies in Patients along with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Presented at the American Society of Clinical Oncology Annual Meeting 30
Jun 06, 2016: TG Therapeutics Announces Lasting Follow-up of TGR-1202 Demonstrates a Differentiated Safety Profile and Higher Response Rates in CLL and NHL in Data Presented at the 52nd Annual Meeting of the American Society of Clinical Oncology 32
May 24, 2016: REDX PHARMA: Proof of tip along with vital oncology lead 33
May 20, 2016: TG Therapeutics Announces Clinical Data Presentations at the Upcoming 21st European Hematology Association Annual Congress 33
About us
MarketResearchReports.biz is the a lot of comprehensive collection of market research reports. MarketResearchReports.Biz solutions are specially made to conserve time and cash for our clients. We are a one avoid solution for all of your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all of dimensions and types of companies spanning across various industries.
Contact us:
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://ift.tt/1eEw6dP
